Clinical Trial Update: Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of Atuliflapon in moderate-to-severe uncontrolled asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Atuliflapon

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED